313 related articles for article (PubMed ID: 8692724)
21. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
[TBL] [Abstract][Full Text] [Related]
22. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
23. Tumor vasculature-targeted
Yoneyama T; Hatakeyama S; Sutoh Yoneyama M; Yoshiya T; Uemura T; Ishizu T; Suzuki M; Hachinohe S; Ishiyama S; Nonaka M; Fukuda MN; Ohyama C
BMC Cancer; 2021 Jan; 21(1):72. PubMed ID: 33446132
[TBL] [Abstract][Full Text] [Related]
24. Boron neutron capture therapy for cancer. Realities and prospects.
Barth RF; Soloway AH; Fairchild RG; Brugger RM
Cancer; 1992 Dec; 70(12):2995-3007. PubMed ID: 1451084
[TBL] [Abstract][Full Text] [Related]
25. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
26. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality.
Barth RF; Zhang Z; Liu T
Cancer Commun (Lond); 2018 Jun; 38(1):36. PubMed ID: 29914575
[TBL] [Abstract][Full Text] [Related]
27. Application of a novel boronated porphyrin (H₂OCP) as a dual sensitizer for both PDT and BNCT.
Hiramatsu R; Kawabata S; Miyatake S; Kuroiwa T; Easson MW; Vicente MG
Lasers Surg Med; 2011 Jan; 43(1):52-8. PubMed ID: 21254143
[TBL] [Abstract][Full Text] [Related]
28. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.
Luderer MJ; de la Puente P; Azab AK
Pharm Res; 2015 Sep; 32(9):2824-36. PubMed ID: 26033767
[TBL] [Abstract][Full Text] [Related]
29. Ligand liposomes and boron neutron capture therapy.
Carlsson J; Kullberg EB; Capala J; Sjöberg S; Edwards K; Gedda L
J Neurooncol; 2003; 62(1-2):47-59. PubMed ID: 12749702
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
[TBL] [Abstract][Full Text] [Related]
31. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
32. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA
Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179
[TBL] [Abstract][Full Text] [Related]
33. Biological evaluation of boronated unnatural amino acids as new boron carriers.
Kabalka GW; Yao ML; Marepally SR; Chandra S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S374-9. PubMed ID: 19398346
[TBL] [Abstract][Full Text] [Related]
34. Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy.
Pan XQ; Wang H; Shukla S; Sekido M; Adams DM; Tjarks W; Barth RF; Lee RJ
Bioconjug Chem; 2002; 13(3):435-42. PubMed ID: 12009931
[TBL] [Abstract][Full Text] [Related]
35. The basis and advances in clinical application of boron neutron capture therapy.
He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
[TBL] [Abstract][Full Text] [Related]
36. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice.
Ono K; Masunaga S; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):431-6. PubMed ID: 10030272
[TBL] [Abstract][Full Text] [Related]
37. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
38. Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy.
Luderer MJ; Muz B; Alhallak K; Sun J; Wasden K; Guenthner N; de la Puente P; Federico C; Azab AK
Pharm Res; 2019 Aug; 36(10):144. PubMed ID: 31392417
[TBL] [Abstract][Full Text] [Related]
39. Boron neutron capture therapy at the crossroads: challenges and opportunities.
Barth RF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
[TBL] [Abstract][Full Text] [Related]
40. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
Trivillin VA; Garabalino MA; Colombo LL; González SJ; Farías RO; Monti Hughes A; Pozzi EC; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
Appl Radiat Isot; 2014 Jun; 88():94-8. PubMed ID: 24360862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
